149 related articles for article (PubMed ID: 21347118)
1. Facilitating Clinical Research through the Health Information Exchange: Lipid Control as an Example.
Zhu VJ; Tu W; Rosenman MB; Overhage JM
AMIA Annu Symp Proc; 2010 Nov; 2010():947-51. PubMed ID: 21347118
[TBL] [Abstract][Full Text] [Related]
2. Adherence to standard-dose or low-dose statin treatment and low-density lipoprotein cholesterol response in type 2 diabetes patients.
de Vries FM; Voorham J; Hak E; Denig P
Curr Med Res Opin; 2015 Dec; 31(12):2197-206. PubMed ID: 26359331
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012.
Wong ND; Young D; Zhao Y; Nguyen H; Caballes J; Khan I; Sanchez RJ
J Clin Lipidol; 2016; 10(5):1109-18. PubMed ID: 27678427
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and treatment patterns in patients with atherosclerotic cardiovascular disease with hypercholesterolemia: a retrospective analysis of a large US real-world database cohort.
Lahoz R; Seshagiri D; Electricwala B; Achouba A; Ding Y; Heo JH; Cristino J; Studer R
Curr Med Res Opin; 2024 Jan; 40(1):15-25. PubMed ID: 37941428
[TBL] [Abstract][Full Text] [Related]
5. Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings.
Shalev V; Goldshtein I; Halpern Y; Chodick G
Pharmacotherapy; 2014 Jan; 34(1):1-8. PubMed ID: 23836549
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Statin Low-Density Lipoprotein Cholesterol Dose-Response Using Electronic Health Records in a Large Population-Based Cohort.
Oni-Orisan A; Hoffmann TJ; Ranatunga D; Medina MW; Jorgenson E; Schaefer C; Krauss RM; Iribarren C; Risch N
Circ Genom Precis Med; 2018 Sep; 11(9):e002043. PubMed ID: 30354326
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
8. DemographIc Assessment and EValuation of DEgree of Lipid Control in High Risk Indian DySlipidemia PatiEnts (DIVERSE Study).
Malhotra N; Keshan MK; Agarwal A; Kumar RA; Trailokya A; Dalvi K; Talele S
J Assoc Physicians India; 2016 Apr; 64(4):38-46. PubMed ID: 27734640
[TBL] [Abstract][Full Text] [Related]
9. Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.
Morieri ML; Perrone V; Veronesi C; Degli Esposti L; Andretta M; Plebani M; Fadini GP; Vigili de Kreutzenberg S; Avogaro A
Cardiovasc Diabetol; 2021 Jul; 20(1):144. PubMed ID: 34271920
[TBL] [Abstract][Full Text] [Related]
10. Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based health care delivery system, 2002-2016.
Romanelli RJ; Ito MK; Karalis DG; Huang HC; Iorga ŞR; Kam IW; Thompson S; Azar KMJ
J Clin Lipidol; 2020; 14(3):305-314. PubMed ID: 32362513
[TBL] [Abstract][Full Text] [Related]
11. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
12. Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study.
Gamboa CM; Colantonio LD; Brown TM; Carson AP; Safford MM
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490523
[TBL] [Abstract][Full Text] [Related]
13. Effect of Patient Financial Incentives on Statin Adherence and Lipid Control: A Randomized Clinical Trial.
Barankay I; Reese PP; Putt ME; Russell LB; Loewenstein G; Pagnotti D; Yan J; Zhu J; McGilloway R; Brennan T; Finnerty D; Hoffer K; Chadha S; Volpp KG
JAMA Netw Open; 2020 Oct; 3(10):e2019429. PubMed ID: 33034639
[TBL] [Abstract][Full Text] [Related]
14. Comparison of on-Statin Lipid and Lipoprotein Levels for the Prediction of First Cardiovascular Event in Type 2 Diabetes Mellitus.
Kim JY; Choi J; Kim SG; Kim NH
Diabetes Metab J; 2023 Nov; 47(6):837-845. PubMed ID: 37915183
[TBL] [Abstract][Full Text] [Related]
15. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
Munkhaugen J; Sverre E; Otterstad JE; Peersen K; Gjertsen E; Perk J; Gullestad L; Moum T; Dammen T; Husebye E
Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
[TBL] [Abstract][Full Text] [Related]
17. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
Virani SS; Kennedy KF; Akeroyd JM; Morris PB; Bittner VA; Masoudi FA; Stone NJ; Petersen LA; Ballantyne CM
Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004652. PubMed ID: 29748356
[TBL] [Abstract][Full Text] [Related]
18. Quantifying Unmet Need in Statin-Treated Hyperlipidemia Patients and the Potential Benefit of Further LDL-C Reduction Through an EHR-Based Retrospective Cohort Study.
Schleyer T; Hui S; Wang J; Zhang Z; Knapp K; Baker J; Chase M; Boggs R; Simpson RJ
J Manag Care Spec Pharm; 2019 May; 25(5):544-554. PubMed ID: 31039062
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care.
Guglielmi V; Bellia A; Pecchioli S; Della-Morte D; Parretti D; Cricelli I; Medea G; Sbraccia P; Lauro D; Cricelli C; Lapi F
Atherosclerosis; 2017 Aug; 263():36-41. PubMed ID: 28599257
[TBL] [Abstract][Full Text] [Related]
20. Statin Dosing Instructions, Medication Adherence, and Low-Density Lipoprotein Cholesterol: a Cohort Study of Incident Statin Users.
Marcum ZA; Huang HC; Romanelli RJ
J Gen Intern Med; 2019 Nov; 34(11):2559-2566. PubMed ID: 31367867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]